{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:53:22Z","timestamp":1790546002361,"version":"4.1.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:00:00Z","timestamp":1208304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001995","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T22:11:02Z","timestamp":1208297462000},"page":"e1995","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection"],"prefix":"10.1371","volume":"3","author":[{"given":"Zhujun","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.","volume":"418","author":"AM Sheehy","year":"2002","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.","volume":"424","author":"H Zhang","year":"2003","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection.","volume":"113","author":"RS Harris","year":"2003","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein.","volume":"300","author":"D Lecossier","year":"2003","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.","volume":"424","author":"B Mangeat","year":"2003","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","article-title":"Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.","volume":"114","author":"R Mariani","year":"2003","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature03493","article-title":"Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.","volume":"435","author":"YL Chiu","year":"2005","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","article-title":"Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.","volume":"15","author":"EN Newman","year":"2005","journal-title":"Curr Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"33177","DOI":"10.1074\/jbc.M402062200","article-title":"The interaction between HIV-1 Gag and APOBEC3G.","volume":"279","author":"S Cen","year":"2004","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"34083","DOI":"10.1074\/jbc.C400235200","article-title":"APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein.","volume":"279","author":"TM Alce","year":"2004","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.79.13.8201-8207.2005","article-title":"Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.","volume":"79","author":"BP Doehle","year":"2005","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.78.21.11841-11852.2004","article-title":"Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.","volume":"78","author":"K Luo","year":"2004","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2004.08.006","article-title":"Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.","volume":"328","author":"A Schafer","year":"2004","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"35822","DOI":"10.1074\/jbc.M405761200","article-title":"Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.","volume":"279","author":"ES Svarovskaia","year":"2004","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"12058","DOI":"10.1128\/JVI.78.21.12058-12061.2004","article-title":"APOBEC3G incorporation into human immunodeficiency virus type 1 particles.","volume":"78","author":"V Zennou","year":"2004","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.02237-06","article-title":"APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.","volume":"81","author":"A Burnett","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.","volume":"12","author":"K Stopak","year":"2003","journal-title":"Mol Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.","volume":"9","author":"AM Sheehy","year":"2003","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.","volume":"9","author":"M Marin","year":"2003","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.","volume":"302","author":"X Yu","year":"2003","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.","volume":"18","author":"Y Yu","year":"2004","journal-title":"Genes Dev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.77.21.11398-11407.2003","article-title":"The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.","volume":"77","author":"S Kao","year":"2003","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","article-title":"The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.","volume":"13","author":"SG Conticello","year":"2003","journal-title":"Curr Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-1-27","article-title":"Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.","volume":"1","author":"S Kao","year":"2004","journal-title":"Retrovirology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2007.08.005","article-title":"Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.","volume":"369","author":"S Kao","year":"2007","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1128\/JVI.02694-06","article-title":"Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.","volume":"81","author":"S Opi","year":"2007","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0307713101","article-title":"A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.","volume":"101","author":"HP Bogerd","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14481","DOI":"10.1074\/jbc.C400060200","article-title":"A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action.","volume":"279","author":"B Mangeat","year":"2004","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.0307132101","article-title":"A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).","volume":"101","author":"B Schrofelbauer","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.0400830101","article-title":"A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.","volume":"101","author":"H Xu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JVI.02795-06","article-title":"Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.","volume":"81","author":"H Huthoff","year":"2007","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/JVI.69.11.7032-7044.1995","article-title":"Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.","volume":"69","author":"XJ Yao","year":"1995","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1128\/JVI.67.12.7229-7237.1993","article-title":"Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational analysis.","volume":"67","author":"W Paxton","year":"1993","journal-title":"J. Virol."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.67.11.6542-6550.1993","article-title":"Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.","volume":"67","author":"YL Lu","year":"1993","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JVI.69.5.2759-2764.1995","article-title":"The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.","volume":"69","author":"E Kondo","year":"1995","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/JVI.68.3.1926-1934.1994","article-title":"Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.","volume":"68","author":"C Lavallee","year":"1994","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.69.6.3389-3398.1995","article-title":"Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.","volume":"69","author":"X Wu","year":"1995","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.1996.0253","article-title":"Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.","volume":"219","author":"X Wu","year":"1996","journal-title":"Virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1093\/emboj\/16.16.5113","article-title":"Functional RT and IN incorporated into HIV-1 particles independently of the Gag\/Pol precursor protein.","volume":"16","author":"X Wu","year":"1997","journal-title":"Embo J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.72.7.5441-5448.1998","article-title":"Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.","volume":"72","author":"GP Kobinger","year":"1998","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.gt.3300988","article-title":"HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.","volume":"6","author":"XJ Yao","year":"1999","journal-title":"Gene Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1093\/emboj\/16.16.5123","article-title":"Complementation of integrase function in HIV-1 virions.","volume":"16","author":"TM Fletcher 3rd","year":"1997","journal-title":"Embo J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00042560-199604010-00004","article-title":"Targeting a foreign protein into virion particles by fusion with the Vpx protein of simian immunodeficiency virus.","volume":"11","author":"IW Park","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.78.6.3170-3177.2004","article-title":"Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system.","volume":"78","author":"Z Ao","year":"2004","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/JVI.66.4.2232-2239.1992","article-title":"Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated b-galactosidase gene.","volume":"66","author":"J Kimpton","year":"1992","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2003.11.021","article-title":"Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.","volume":"319","author":"KL Nguyen","year":"2004","journal-title":"Virology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1128\/JVI.00839-06","article-title":"Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.","volume":"80","author":"KN Bishop","year":"2006","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.M607298200","article-title":"APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.","volume":"282","author":"RK Holmes","year":"2007","journal-title":"J Biol Chem"},{"key":"ref49","article-title":"Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. Virology.","author":"Y Yang","year":"2007"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-4690-2-62","article-title":"Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import.","volume":"2","author":"Z Ao","year":"2005","journal-title":"Retrovirology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/85664","article-title":"Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo.","volume":"19","author":"GP Kobinger","year":"2001","journal-title":"Nat Biotechnol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(93)90073-Y","article-title":"Induction of cell differentiation by human immunodeficiency virus 1 vpr.","volume":"72","author":"DN Levy","year":"1993","journal-title":"Cell"},{"key":"ref53","first-page":"882","article-title":"The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection. J. Virol.","volume":"69","author":"ME Rogel","year":"1995"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.","volume":"69","author":"J He","year":"1995","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1128\/JVI.69.11.6859-6864.1995","article-title":"Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.","volume":"69","author":"F Re","year":"1995","journal-title":"J. Virol."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1128\/JVI.72.6.4686-4693.1998","article-title":"Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.","volume":"72","author":"XJ Yao","year":"1998","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1074\/jbc.M313093200","article-title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.","volume":"279","author":"A Mehle","year":"2004","journal-title":"J Biol Chem"},{"key":"ref58","article-title":"VPR.A3A chimera inhibits HIV replication. J Biol Chem.","author":"RS Aguiar","year":"2007"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1128\/JVI.70.12.8701-8709.1996","article-title":"Role of Vif in human immunodeficiency virus type 1 reverse transcription.","volume":"70","author":"J Goncalves","year":"1996","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jcb.20082","article-title":"Functional domains of APOBEC3G required for antiviral activity.","volume":"92","author":"J Li","year":"2004","journal-title":"J Cell Biochem"},{"key":"ref61","article-title":"The interaction of APOBEC3G with HIV-1 nucleocapsid inhibits tRNALys3 annealing to viral RNA. J Virol.","author":"F Guo","year":"2007"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.01038-06","article-title":"Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.","volume":"80","author":"F Guo","year":"2006","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.20051856","article-title":"Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.","volume":"203","author":"JF Kreisberg","year":"2006","journal-title":"J Exp Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/emboj\/17.4.909","article-title":"Viral protein R regulates nuclear import of HIV-1 pre-integration complex.","volume":"17","author":"S Popov","year":"1998","journal-title":"EMBO J."},{"key":"ref65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.dnarep.2006.10.001","article-title":"The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.","volume":"6","author":"HA Coker","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.0105-2896.2005.00232.x","article-title":"DNA deamination in immunity.","volume":"203","author":"S Petersen-Mahrt","year":"2005","journal-title":"Immunol Rev"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.1074\/jbc.M610546200","article-title":"Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication.","volume":"282","author":"Z Ao","year":"2007","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","article-title":"The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.","volume":"10","author":"GB Cohen","year":"1999","journal-title":"Immunity"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/viro.1995.1293","article-title":"Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity.","volume":"209","author":"XJ Yao","year":"1995","journal-title":"Virology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1128\/JVI.72.6.4686-4693.1998","article-title":"Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.","volume":"72","author":"XJ Yao","year":"1998","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1128\/JVI.70.8.5297-5305.1996","article-title":"The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.","volume":"70","author":"JHM Simon","year":"1996","journal-title":"J. Virol."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T10:45:04Z","timestamp":1588589104000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001995"}},"subtitle":[],"editor":[{"given":"Linqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,16]]},"references-count":71,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001995","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,16]]}}}